Back
Geron Vs. Actinium Pharmaceuticals Industry Stock Comparison
Sell
40
GERN
Geron
Last Price:
4.42
Seasonality Move:
5.08%
Sell
25
ATNM
Actinium Pharmaceuticals
Last Price:
1.76
Seasonality Move:
4.44%
Sell
40
Geron (GERN)
is a Sell
Is Geron a Buy, Sell or Hold?
- The current Geron [GERN] share price is $4.51. The Score for GERN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- GERN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $1.86. The Score for ATNM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GERN Stock Price Chart
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $1.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing selling pressure, which indicates risk of future bearish movement.
GERN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 51.31 | Buy |
| Chaikin Money Flow: | -5500938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.37 - 4.63) | Buy |
| Bollinger Bands (100): | (3.88 - 4.74) | Buy |
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 30.36 | Sell |
| Chaikin Money Flow: | -177645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.84 - 2.06) | Sell |
| Bollinger Bands (100): | (3.43 - 8.93) | Sell |
GERN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.37 | Buy |
| 20-day SMA: | 4.48 | Buy |
| 50-day SMA: | 4.57 | Sell |
| 200-day SMA: | 3.35 | Buy |
| 8-day EMA: | 4.43 | Buy |
| 20-day EMA: | 4.46 | Buy |
| 50-day EMA: | 4.45 | Buy |
| 200-day EMA: | 3.68 | Buy |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.85 | Buy |
| 20-day SMA: | 1.94 | Sell |
| 50-day SMA: | 4.23 | Sell |
| 200-day SMA: | 6.29 | Sell |
| 8-day EMA: | 1.89 | Sell |
| 20-day EMA: | 2.22 | Sell |
| 50-day EMA: | 3.71 | Sell |
| 200-day EMA: | 5.98 | Sell |
Geron Earnings Growth & GERN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.00 per share, and an increase next year of $0.26 per share.
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.
Geron Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Actinium Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||